These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 9657034

  • 1. [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
    Rabii R, el Moussaoui A, Rais H, Joual A, Debbagh A, el Mrini M, Benjelloun S.
    Ann Urol (Paris); 1998; 32(3):166-71. PubMed ID: 9657034
    [Abstract] [Full Text] [Related]

  • 2. [Bladder tumors in young patients].
    Aboutaieb R, Dakir M, Sarrf I, el Moussaoui A, Bennani S, el Mrini M, Meziane F, Benjelloun S.
    Prog Urol; 1998 Feb; 8(1):43-6. PubMed ID: 9533150
    [Abstract] [Full Text] [Related]

  • 3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Feb; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 4. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 6. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Mar; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 7. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA, Kashmoula DM, Haddad LF.
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [Abstract] [Full Text] [Related]

  • 8. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [Abstract] [Full Text] [Related]

  • 9. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH, Bai JL, Zhang SS, Ma PC, Wan JH.
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [Abstract] [Full Text] [Related]

  • 10. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C.
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [Abstract] [Full Text] [Related]

  • 11. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

  • 12. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
    Raitanen MP, Tammela TL.
    Ann Chir Gynaecol; 1995 May; 84(1):37-41. PubMed ID: 7645909
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y.
    Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [Abstract] [Full Text] [Related]

  • 17. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jan; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 20. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F, Schuster F.
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.